Mark Cuban Reveals How Wholesalers Coerce Pharmacies into Nearly Exclusive Agreements, Highlighting PBMs' 'Stranglehold' on Medication Costs
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 08 2025
0mins
Source: Benzinga
Mark Cuban's Critique of the Drug Industry: Mark Cuban criticized the U.S. prescription drug industry on social media, accusing wholesalers and Pharmacy Benefit Managers (PBMs) of manipulating prices through anti-competitive practices that inflate costs for consumers.
Opaque Pricing Mechanisms: Cuban explained how pharmacies are coerced into exclusive purchasing agreements with wholesalers, leading to artificially inflated prices and complicated rebate schemes that ultimately disadvantage patients and make the system difficult to navigate.
Analyst Views on PPH
Wall Street analysts forecast PPH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PPH is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 106.420
Low
Averages
High
Current: 106.420
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
